Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
University of Kansas Medical Center
University of Kansas Medical Center
Alliance for Clinical Trials in Oncology
National University Hospital, Singapore
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
St. Joseph's Hospital and Medical Center, Phoenix
Assistance Publique - Hôpitaux de Paris
University of Nottingham
University of Aarhus
Imperial College London
University of Aberdeen
CHU de Reims
Assiut University
University of Virginia
Northwestern University
M.D. Anderson Cancer Center
Ottawa Hospital Research Institute
Assiut University
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Assiut University
University of Aberdeen
Massachusetts General Hospital
AHS Cancer Control Alberta
NHS Greater Glasgow and Clyde
Universitaire Ziekenhuizen KU Leuven
NHS Greater Glasgow and Clyde
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Mahidol University
Odense University Hospital
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
University of Zurich
Hadassah Medical Organization
Radboud University Medical Center
Hospices Civils de Lyon